Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 to 80 years old who have been diagnosed with peripheral artery disease (PAD) — a condition causing leg pain during walking — with a specific test result confirming reduced blood flow to the legs.
- Adults aged 18 to 80 years old who have never been diagnosed with peripheral artery disease (PAD).
- People who are willing and able to sign a consent form and follow the study procedures.
Who may not be able to join:
- People who are unable or unwilling to sign a consent form or provide a blood sample.
- People with a serious illness that doctors expect may result in death within two years.
- People with an active cancer diagnosis that is not considered cured (basal cell skin cancer is an exception). Cancer is generally considered cured if there has been no sign of it returning in the past five years.
- People with high blood pressure that is not well controlled by treatment.
- People with a very severe form of heart failure, classified as New York Heart Association Class IV (confirm with trial site).
- People with active liver disease or poor liver function.
- People with active kidney disease or poor kidney function.
- People with a history of bleeding stroke or another major bleeding condition.
- People with a white blood cell count at or above a certain high level detected in a blood test (confirm with trial site).
- People with an active infection currently being treated with antibiotic or antiviral medicines.
- People with HIV/AIDS.
- People currently taking oral steroid medicines (such as prednisone) or other medicines that suppress the immune system (such as methotrexate).
- People who have an autoimmune disorder that has been or is being treated.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Subodh Verma, MD, University of Toronto
Phone: 604-703-5449
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The difference in the frequency / absolute number of circulating primitive myeloid progenitor cells (ALDHhiSSClow) between individuals with PAD and without PAD
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.